ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2) gene is amplified in 20% of breast cancers and is associated with significantly more aggressive disease course including increased recurrence rate in localized disease and shortened overall survival in metastatic disease12.